|
HY-137499-25mg
|
MedChemexpress LLC
|
NT1-O12B [CAS 2739805-63-9]
|
|
|
|
|
HY-137499-5mg
|
MedChemexpress LLC
|
NT1-O12B [CAS 2739805-63-9]
|
|
|
|
|
HY-137499-50mg
|
MedChemexpress LLC
|
NT1-O12B [CAS 2739805-63-9]
|
|
|
|
|
HY-137499-1mL
|
MedChemexpress LLC
|
NT1-O12B [CAS 2739805-63-9] (10mM in DMSO)
|
|
|
|
|
HY-P99807-1mg
|
MedChemexpress LLC
|
Prolgolimab [CAS 2093956-19-3]
|
|
Cancer-programmed cell death
|
|
|
HY-P99807-10mg
|
MedChemexpress LLC
|
Prolgolimab [CAS 2093956-19-3]
|
|
Cancer-programmed cell death
|
|
|
HY-P99807-5mg
|
MedChemexpress LLC
|
Prolgolimab [CAS 2093956-19-3]
|
|
Cancer-programmed cell death
|
|
|
HY-148130-1mg
|
MedChemexpress LLC
|
Rugonersen [CAS 2591587-57-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-148130-10mg
|
MedChemexpress LLC
|
Rugonersen [CAS 2591587-57-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-148130-5mg
|
MedChemexpress LLC
|
Rugonersen [CAS 2591587-57-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-152038-10mg
|
MedChemexpress LLC
|
SPEN-IN-1 [CAS 2863686-82-0]
|
|
|
|
|
HY-152038-100mg
|
MedChemexpress LLC
|
SPEN-IN-1 [CAS 2863686-82-0]
|
|
|
|
|
HY-152038-25mg
|
MedChemexpress LLC
|
SPEN-IN-1 [CAS 2863686-82-0]
|
|
|
|
|
HY-152038-5mg
|
MedChemexpress LLC
|
SPEN-IN-1 [CAS 2863686-82-0]
|
|
|
|
|
HY-152038-50mg
|
MedChemexpress LLC
|
SPEN-IN-1 [CAS 2863686-82-0]
|
|
|
|
|
HY-152038-1mL
|
MedChemexpress LLC
|
SPEN-IN-1 [CAS 2863686-82-0] (10mM in DMSO)
|
|
|
|
|
HY-P71397-10ug
|
MedChemexpress LLC
|
UBE2A, Human (GST-His)
|
|
|
|
|
HY-P71397-100ug
|
MedChemexpress LLC
|
UBE2A, Human (GST-His)
|
|
|
|
|
HY-P71397-5ug
|
MedChemexpress LLC
|
UBE2A, Human (GST-His)
|
|
|
|
|
HY-P71397-50ug
|
MedChemexpress LLC
|
UBE2A, Human (GST-His)
|
|
|
|
|
HY-147087-10mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
|
HY-147087-100mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
|
HY-147087-25mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
|
HY-147087-5mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
|
HY-147087-50mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
